Compounds > 2,3-dimethylmaleic anhydride
Page last updated: 2024-08-21

2,3-dimethylmaleic anhydride and ER-Negative PR-Negative HER2-Negative Breast Cancer

2,3-dimethylmaleic anhydride has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Cao, Z; Hua, Z; Li, Y; Liu, R; Liu, Y; Lu, A; Lu, C; Luo, X; Wang, X; Xue, Z; Zhang, Z1

Other Studies

1 other study(ies) available for 2,3-dimethylmaleic anhydride and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
MTX-PEG-modified CG/DMMA polymeric micelles for targeted delivery of doxorubicin to induce synergistic autophagic death against triple-negative breast cancer.
    Breast cancer research : BCR, 2023, 01-12, Volume: 25, Issue:1

    Topics: Breast Neoplasms; Cell Line, Tumor; Doxorubicin; Female; Humans; Methotrexate; Micelles; Polymers; Triple Negative Breast Neoplasms

2023